{"title":"作者更正:工程低氧反应白蛋白纳米颗粒介导癌症治疗的自噬调节","authors":"Wenyan Wang, Shun-Yu Yao, Jingjing Luo, Chendi Ding, Qili Huang, Yao Yang, Zhaoqing Shi, Jiachan Lin, Yu-Chen Pan, Xiaowei Zeng, Dong-Sheng Guo, Hongzhong Chen","doi":"10.1038/s41467-025-57018-y","DOIUrl":null,"url":null,"abstract":"<p>In the version of the article initially published, ref. 9 was incorrect and has now been amended to Bhandari, V. et al. Molecular landmarks of tumor hypoxia across cancer types. <i>Nat. Genet.</i> <b>51</b>, 308–318 (2019) and ref. 49 was incomplete and has now been amended to Hu, X. Y. et al. Hypoxia-responsive host-guest drug delivery system. <i>Acc. Mater. Res.</i>, <b>4</b>, 925–938 (2023). The original article has been corrected.</p>","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"12 1","pages":""},"PeriodicalIF":15.7000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Author Correction: Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy\",\"authors\":\"Wenyan Wang, Shun-Yu Yao, Jingjing Luo, Chendi Ding, Qili Huang, Yao Yang, Zhaoqing Shi, Jiachan Lin, Yu-Chen Pan, Xiaowei Zeng, Dong-Sheng Guo, Hongzhong Chen\",\"doi\":\"10.1038/s41467-025-57018-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In the version of the article initially published, ref. 9 was incorrect and has now been amended to Bhandari, V. et al. Molecular landmarks of tumor hypoxia across cancer types. <i>Nat. Genet.</i> <b>51</b>, 308–318 (2019) and ref. 49 was incomplete and has now been amended to Hu, X. Y. et al. Hypoxia-responsive host-guest drug delivery system. <i>Acc. Mater. Res.</i>, <b>4</b>, 925–938 (2023). The original article has been corrected.</p>\",\"PeriodicalId\":19066,\"journal\":{\"name\":\"Nature Communications\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":15.7000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Communications\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://doi.org/10.1038/s41467-025-57018-y\",\"RegionNum\":1,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Communications","FirstCategoryId":"103","ListUrlMain":"https://doi.org/10.1038/s41467-025-57018-y","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
在文章最初发表的版本中,参考文献 9 有误,现已修改为 Bhandari, V. et al.9 有误,现已修改为 Bhandari, V. et al. 跨癌症类型的肿瘤缺氧分子标志。Nat.Genet.51, 308-318 (2019) and ref.49 was incomplete and has now been amended to Hu, X. Y. et al. Hypoxia-responsive host-guest drug delivery system.Acc.Mater.Res., 4, 925-938 (2023)。原文已更正。
Author Correction: Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy
In the version of the article initially published, ref. 9 was incorrect and has now been amended to Bhandari, V. et al. Molecular landmarks of tumor hypoxia across cancer types. Nat. Genet.51, 308–318 (2019) and ref. 49 was incomplete and has now been amended to Hu, X. Y. et al. Hypoxia-responsive host-guest drug delivery system. Acc. Mater. Res., 4, 925–938 (2023). The original article has been corrected.
期刊介绍:
Nature Communications, an open-access journal, publishes high-quality research spanning all areas of the natural sciences. Papers featured in the journal showcase significant advances relevant to specialists in each respective field. With a 2-year impact factor of 16.6 (2022) and a median time of 8 days from submission to the first editorial decision, Nature Communications is committed to rapid dissemination of research findings. As a multidisciplinary journal, it welcomes contributions from biological, health, physical, chemical, Earth, social, mathematical, applied, and engineering sciences, aiming to highlight important breakthroughs within each domain.